z-logo
open-access-imgOpen Access
Spiroethers of German chamomile inhibit production of aflatoxin G 1 and trichothecene mycotoxin by inhibiting cytochrome P450 monooxygenases involved in their biosynthesis
Author(s) -
Yoshinari Tomoya,
Yaguchi Atsushi,
TakahashiAndo Naoko,
Kimura Makoto,
Takahashi Haruo,
Nakajima Takashi,
SugitaKonishi Yoshiko,
Nagasawa Hiromichi,
Sakuda Shohei
Publication year - 2008
Publication title -
fems microbiology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.899
H-Index - 151
eISSN - 1574-6968
pISSN - 0378-1097
DOI - 10.1111/j.1574-6968.2008.01195.x
Subject(s) - trichothecene , monooxygenase , mycotoxin , aflatoxin , cytochrome p450 , biosynthesis , cytochrome , chemistry , biology , biochemistry , food science , gene , enzyme
The essential oil of German chamomile showed specific inhibition toward aflatoxin G 1 (AFG 1 ) production, and ( E )‐ and ( Z )‐spiroethers were isolated as the active compounds from the oil. The ( E )‐ and ( Z )‐spiroethers inhibited AFG 1 production of Aspergillus parasiticus with inhibitory concentration 50% (IC 50 ) values of 2.8 and 20.8 μM, respectively, without inhibiting fungal growth. Results of an O‐ methylsterigmatocystin (OMST) conversion study indicated that the spiroethers specifically inhibited the OMST to AFG 1 pathway. A cytochrome P450 monooxygenase, CYPA, is known as an essential enzyme for this pathway. Because CYPA has homology with TRI4, a key enzyme catalyzing early steps in the biosynthesis of trichothecenes, the inhibitory actions of the two spiroethers against TRI4 reactions and 3‐acetyldeoxynivalenol (3‐ADON) production were tested. ( E ) ‐ and ( Z ) ‐ spiroethers inhibited the enzymatic activity of TRI4 dose‐dependently and interfered with 3‐ADON production by Fusarium graminearum , with IC 50 values of 27.1 and 103 μM, respectively. Our results suggest that the spiroethers inhibited AFG 1 and 3‐ADON production by inhibiting CYPA and TRI4, respectively.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here